No Data
No Data
BMO Capital Maintains Polaris(PII.US) With Hold Rating, Cuts Target Price to $50
Polaris Stock Falls After Hosting Annual Investor Day
SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
Polaris Sees Powersports Industry 8% Lower Than Pre-Covid Averages
PolarisAR STELLAR Knee Surgical Guidance System Recognized for Innovation
Polaris' (NYSE:PII) Earnings Have Declined Over Three Years, Contributing to Shareholders 50% Loss
TheCarmelizer : Good shot!
Peasant Investor OP TheCarmelizer : Thanks sir![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)